About Technology Issues FAQ

Links

cGMP production and analysis of BG505 SOSIP.664, an extensively glycosylated, trimeric HIV‐1 envelope glycoprotein vaccine candidate

cGMP production and analysis of BG505 SOSIP.664, an extensively glycosylated, trimeric HIV‐1 envelope glycoprotein vaccine candidate — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.